This is a temporary backup site for TRENDS MENA while our primary website is being restored following a regional disruption affecting AWS cloud infrastructure in the GCC.

Search Site

AD Ports Group 2024 net profit $484m

The Group's revenue increased 48 percent year-on-year.

TAQA net income $1.93bn in 2024

The company's revenues increased 6.7 percent year-on-year.

ADNOC L&S 2024 net profit $756m

The company's revenue increased by 29 percent to $3.54 billion.

ADNOC Distribution 2024 net profit down 7%

Minus UAE corporate tax, it would have grown by 2.4% to $725m

Maaden raises $1.25bn in sukuk offering

The Sukuk were offered in a five-year and a 10-year tranche.

UAE children aged 3-17 to receive Chinese Sinopharm vaccine

    • The Gulf state, which has among the world’s highest immunization rates, was already providing the Pfizer-BioNTech vaccine for children aged 12-15

    • The UAE government took to twitter to make the announcement

    The United Arab Emirates has decided to inoculate children between the ages of 3 and 17 with Chinese Covid-19 vaccine Sinopharm. Although the Chinese vaccines have been criticized for their low efficacy, the UAE was still going ahead to vaccinate the younger children with the Sinopharm vaccine.

    The UAE government took to twitter to make the announcement. It cited the health ministry as saying the decision comes after clinical trials and extensive evaluations, without providing any details. Authorities said in June the trial would monitor the immune response of 900 children.

    The Gulf state, which has among the world’s highest immunization rates, was already providing the Pfizer-BioNTech vaccine for children aged 12-15.

    The health ministry said on Sunday that 78.95 percent of the UAE population of roughly 9 million had received one vaccine dose while 70.57 percent had been fully vaccinated.

    The UAE, the region’s tourism and trade hub, registered 1,519 new coronavirus infections on Sunday to take its total to 682,377 cases and 1,951 deaths. It does not provide a breakdown for each of its seven emirates.

    It led Phase III clinical trials of the vaccine produced by China’s state-owned drugmaker Sinopharm and has started manufacturing it under a joint venture between Sinopharm and Abu Dhabi-based technology company Group 42.